|
Q2 2021
Filed on Aug 16, 2021
|
93,198
|
$59.02 - $78.8
$5.5M - $7.34M
|
|
Dragoneer Growth Opportun CO
|
Q2 2021
Filed on Aug 16, 2021
|
4,675,540
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
645,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
2,170
|
$51.18 - $63.61
$111K - $138K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
250,000
|
$180.16 - $284.48
$45M - $71.1M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
655,500
|
$33.03 - $42.24
$21.7M - $27.7M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
750,000
|
N/A
|
|
Soaring Eagle Acquisition CO
|
Q2 2021
Filed on Aug 16, 2021
|
631,807
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
1,105,782
|
$58.3 - $67.16
$64.5M - $74.3M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
237,503
|
N/A
|
|
Khosla Ventures Acqustn CO I
|
Q2 2021
Filed on Aug 16, 2021
|
750,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
750,000
|
$9.88 - $10.57
$7.41M - $7.93M
|
|
Independence Holdings Corp
|
Q2 2021
Filed on Aug 16, 2021
|
400,000
|
N/A
|
|
Ftac Olympus Acquisition Cor
|
Q2 2021
Filed on Aug 16, 2021
|
1,096,500
|
N/A
|
|
Khosla Ventures Acqut CO Iii
|
Q2 2021
Filed on Aug 16, 2021
|
750,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
891,500
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
1,925,983
|
$51.18 - $63.61
$98.6M - $123M
|
|
Dragoneer Growth Opportun CO
|
Q1 2021
Filed on May 17, 2021
|
2,000,000
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
1,000
|
$38.94 - $50.85
$38.9K - $50.9K
|
|
|
Q1 2021
Filed on May 17, 2021
|
643,090
|
$44.3 - $61.92
$28.5M - $39.8M
|
|
|
Q1 2021
Filed on May 17, 2021
|
733,960
|
$74.31 - $89.94
$54.5M - $66M
|
|
|
Q1 2021
Filed on May 17, 2021
|
791,694
|
$82.18 - $102.27
$65.1M - $81M
|
|
|
Q1 2021
Filed on May 17, 2021
|
494,357
|
$98.2 - $116.23
$48.5M - $57.5M
|
|
|
Q1 2021
Filed on May 17, 2021
|
185,020
|
$368.79 - $397.26
$68.2M - $73.5M
|
|
|
Q1 2021
Filed on May 17, 2021
|
98,144
|
$425.47 - $509.13
$41.8M - $50M
|
|
|
Q1 2021
Filed on May 17, 2021
|
956,263
|
$57.34 - $71.36
$54.8M - $68.2M
|
|
|
Q1 2021
Filed on May 17, 2021
|
314,988
|
$47.16 - $54.44
$14.9M - $17.1M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
695,427
|
$82.6 - $97.91
$57.4M - $68.1M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
4,730
|
$101.66 - $113.44
$481K - $537K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
160,112
|
$222.0 - $317.14
$35.5M - $50.8M
|
|
Proteostasis Therapeutics In
|
Q4 2020
Filed on Feb 16, 2021
|
659,350
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
492,283
|
$123.97 - $151.18
$61M - $74.4M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
358,008
|
$4.87 - $17.29
$1.74M - $6.19M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
497,449
|
$45.01 - $65.47
$22.4M - $32.6M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
200,000
|
$82.79 - $172.29
$16.6M - $34.5M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
240,859
|
$160.44 - $184.86
$38.6M - $44.5M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
959,856
|
$50.8 - $68.4
$48.8M - $65.7M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
623,875
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
883,208
|
$30.87 - $41.23
$27.3M - $36.4M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
30,959
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
662,491
|
$28.6 - $74.36
$18.9M - $49.3M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
5,565
|
$53.07 - $61.1
$295K - $340K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
319,923
|
$104.49 - $118.88
$33.4M - $38M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
333,333
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 16, 2020
|
185,952
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
6,000
|
$31.75 - $37.25
$191K - $224K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
651,688
|
$25.93 - $33.12
$16.9M - $21.6M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
440,233
|
$80.93 - $91.1
$35.6M - $40.1M
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
492,470
|
N/A
|
|
|
Q2 2020
Filed on Aug 14, 2020
|
67,979
|
$104.99 - $141.07
$7.14M - $9.59M
|
|